NEW YORK UNIVERSITY IMAGE: NYUAD’S RESEARCH SCIENTIST FARAH BENYETTOU AND PROGRAM HEAD OF CHEMISTRY ALI TRABOLSI CREDIT: NYU ABU DHABI A revolutionary technology developed within the Trabolsi Research Group at NYU Abu Dhabi (NYUAD) could dramatically improve the well-being of diabetic patients through a simple and straightforward way: an insulin oral delivery system that could replace traditional subcutaneous injections...
